“Dr. Lester's prevention-focused approach complements uBiome’s mission of translating cutting-edge microbiome research into actionable tools to improve quality of life. We’re delighted to welcome her to our Medical Advisory Board.” Dr. Jessica Richman, PhD
SAN FRANCISCO (PRWEB) June 29, 2018
uBiome, the leader in microbial genomics, announces the addition of Dr. Tiffany Lester, a San Francisco-based doctor and Medical Director of Parsley Health San Francisco, to its Medical Advisory Board. Joining leading scientists and doctors from around the world, Dr. Lester will bring to uBiome her extensive knowledge on the role of nutrition in disease prevention. The appointment will help uBiome continue its advancement in human microbiome research, as it relates to nutritional health, and further its mission to improve people’s lives.
“Dr. Lester has a proven track record of turning the science behind gut health into actionable lifestyle interventions,” says Dr. Jessica Richman, PhD, co-founder and CEO of uBiome. “Her prevention-focused approach complements uBiome’s mission of translating cutting-edge microbiome research into actionable tools to improve quality of life. We’re delighted to welcome Dr. Lester to our Medical Advisory Board.”
Dr. Lester has devoted her career to a patient-centered approach focused on prevention, including the importance of diet and gut health. After receiving her MD in Internal Medicine from the University of Cincinnati Medical College, Dr. Lester graduated from the Integrative Medicine Fellowship at the University of Arizona, and holds further certification in medical acupuncture. Dr. Lester brings a multifaceted approach to illness and wellness in her role at Parsley Health. Her practice emphasizes the role of gut health, including the gut microbiome, in promoting overall wellness.
In addition to promoting gut health through patient interaction, Dr. Lester also spreads the principles of her approach through popular outlets such as The Huffington Post, MindBodyGreen, and Thoughtfully Magazine. Other honors include being a SXSW panelist at the Inaugural Wellness Expo (2018), one of 33 Self-Care Sistahs That Helped Redefine Wellness by Essence magazine (2017), and one of 26 Women of Color Changing the Face of Wellness by Thoughtfully magazine (2017). Dr. Lester was also voted one of Cincinnati's Best Doctors (2015-2016).
About joining uBiome's Medical Advisory Board, Dr. Lester said, “I believe that by caring for the fundamentals of health, from nutrition to the microbiome, we can treat the root cause of disease and promote overall well being. That’s why I’m thrilled to help uBiome advance its mission and promote patient understanding of the role of the microbiome in human health.”
uBiome’s technology platform is based on the largest microbial dataset in the world (over 250,000 samples), covered by six issued patents (and over 100 pending applications), and used in over 20 peer-reviewed publications and presentations. This platform has been used by over 200 research institutions around the world, including the US Centers for Disease Control (CDC), US National Institutes of Health (NIH), Harvard University, Stanford University, University of California, San Francisco, University College London, and University of Sydney.
In addition to Dr. Lester, the uBiome Scientific Advisory Board also includes Dr. Joseph DeRisi (MacArthur Genius and UCSF professor), Dr. Atul Butte (head of the Institute for Computational Health Sciences at UCSF), Dr. Katherine Pollard (Director, Gladstone Institute for Data Science and Biotechnology), Dr. Joel Palefsky (UCSF School of Medicine professor), Dr. George Church (leading geneticist at Harvard University), Dr. Elaine Hsiao, PhD, Dr. Cynthia Geyer (Medical Director of Canyon Ranch, Lenox), Dr. Jennifer Gardy, PhD, Dr. Jennifer Balkus, Dr. Michael Breus, and other leading scientists. The company’s Medical Advisory Board includes Dr. Alan Green (Society for Participatory Medicine), Dr. Leo Treyzon (Cedars-Sinai Medical Center), Dr. Robynne Chutkan (Georgetown University Hospital), Michael Docktor (Boston Children’s Hospital), Dr. Joel Kahn (Founder of the Kahn Center for Cardiac Longevity), as well as other accomplished clinicians.
Founded in 2012, uBiome is the world’s leading microbial genomics company with a mission to advance the science of the microbiome and make useful products to improve human life. uBiome is funded by Y Combinator, Andreessen Horowitz, and 8VC, as well as other leading investors. Since its launch, the company has received widespread recognition including CNN 10: Startups to Watch, the IVY Technology Award, CNN Future 30, and was named one of Fast Company’s Most Innovative Companies in Healthcare in 2016 and in Data Science in 2018. Most recently, uBiome was selected as a 2018 Technology Pioneer by the World Economic Forum.